ZBIO logo

ZBIO
Zenas Biopharma Inc.

803
Mkt Cap
$1.28B
Volume
2.32M
52W High
$44.60
52W Low
$6.11
PE Ratio
-2.64
ZBIO Fundamentals
Price
$22.30
Prev Close
$23.37
Open
$23.48
50D MA
$22.89
Beta
1.41
Avg. Volume
877,281.16
EPS (Annual)
-$8.44
P/B
5.02
Rev/Employee
$59,880.24
$1,360.92
Loading...
Loading...
News
all
press releases
ENAVATE's Zenas Bio Pharma add Is a Footnote The Obexelimab Pipeline Is What to Watch
Key PointsENAVATE Added 157,800 shares of Zenas BioPharma worth an estimated $5.19 million (based on quarterly average price...
Nasdaq News: Markets·1d ago
News Placeholder
More News
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Downgraded to "Strong Sell" Rating by Wall Street Zen
Wall Street Zen lowered Zenas BioPharma from a "hold" rating to a "strong sell" rating in a research report on Saturday...
MarketBeat·2d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Rating Lowered to "Strong Sell" at Zacks Research
Zacks Research lowered shares of Zenas BioPharma from a "hold" rating to a "strong sell" rating in a research note on Tuesday...
MarketBeat·3d ago
News Placeholder
HC Wainwright Forecasts Lower Earnings for Zenas BioPharma
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Free Report) - Investment analysts at HC Wainwright dropped their Q1 2026 earnings per share estimates for Zenas BioPharma in a research note issued to investors on Tuesday, March 17th. HC Wainwright analyst M. Caufield now anticipates that the company will earn...
MarketBeat·3d ago
News Placeholder
Citigroup Issues Pessimistic Forecast for Zenas BioPharma (NASDAQ:ZBIO) Stock Price
Citigroup lowered their price target on Zenas BioPharma from $43.00 to $41.00 and set a "buy" rating on the stock in a research report on Tuesday...
MarketBeat·5d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Morgan Stanley increased their price target on Zenas BioPharma from $19.00 to $21.00 and gave the stock an "equal weight" rating in a research note on Tuesday...
MarketBeat·5d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Receives "Buy" Rating from HC Wainwright
HC Wainwright reaffirmed a "buy" rating and set a $44.00 target price on shares of Zenas BioPharma in a report on Tuesday...
MarketBeat·5d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Issues Quarterly Earnings Results
Zenas BioPharma (NASDAQ:ZBIO - Get Free Report) posted its earnings results on Monday. The company reported ($4.54) earnings per share for the quarter, missing analysts' consensus estimates of...
MarketBeat·5d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Stock Price Down 6.2% - What's Next?
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 6.2% - Time to Sell...
MarketBeat·6d ago
News Placeholder
ArrowMark Colorado Holdings LLC Reduces Stock Position in Zenas BioPharma, Inc. $ZBIO
ArrowMark Colorado Holdings LLC lessened its stake in Zenas BioPharma, Inc. (NASDAQ:ZBIO - Free Report) by 24.6% in the third quarter, according to the company in its most recent 13F filing with the...
MarketBeat·7d ago
<
1
2
...
>

Latest ZBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.